Progression and Dissemination of Pulmonary Mycobacterium Avium Infection in a Susceptible Immunocompetent Mouse Model
Authors:
Open Access
- 26 May 2022
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (11) , 5999
Abstract
Pulmonary infections caused by the group of nontuberculosis mycobacteria (NTM), Mycobacterium avium complex (MAC), are a growing public health concern with incidence and mortality steadily increasing globally. Granulomatous inflammation is the hallmark of MAC lung infection, yet reliable correlates of disease progression, susceptibility, and resolution are poorly defined. Unlike widely used inbred mouse strains, mice that carry the mutant allele at the genetic locus sst1 develop human-like pulmonary tuberculosis featuring well-organized caseating granulomas. We characterized pulmonary temporospatial outcomes of intranasal and left intrabronchial M. avium spp. hominissuis (M.av) induced pneumonia in B6.Sst1S mice, which carries the sst1 mutant allele. We utilized traditional semi-quantitative histomorphological evaluation, in combination with fluorescent multiplex immunohistochemistry (fmIHC), whole slide imaging, and quantitative digital image analysis. Followingintrabronchiolar infection with the laboratory M.av strain 101, the B6.Sst1S pulmonary lesions progressed 12–16 weeks post infection (wpi), with plateauing and/or resolving disease by 21 wpi. Caseating granulomas were not observed during the study. Disease progression from 12–16 wpi was associated with increased acid-fast bacilli, area of secondary granulomatous pneumonia lesions, and Arg1+ and double positive iNOS+/Arg1+ macrophages. Compared to B6 WT, at 16 wpi, B6.Sst1S lungs exhibited an increased area of acid-fast bacilli, larger secondary lesions with greater Arg1+ and double positive iNOS+/Arg1+ macrophages, and reduced T cell density. This morphomolecular analysis of histologic correlates of disease progression in B6.Sst1S could serve as a platform for assessment of medical countermeasures against NTM infection.Keywords
Funding Information
- National Institutes of Health (R01 HL126066, R01 HL133190, S10OD026983, S10OD030269)
This publication has 57 references indexed in Scilit:
- The sst1 Resistance Locus Regulates Evasion of Type I Interferon Signaling by Chlamydia pneumoniae as a Disease Tolerance MechanismPLOS Pathogens, 2013
- Dominant Role of the sst1 Locus in Pathogenesis of Necrotizing Lung Granulomas during Chronic Tuberculosis Infection and Reactivation in Genetically Resistant HostsThe American Journal of Pathology, 2009
- Visualization of IFNβ production by plasmacytoid versus conventional dendritic cells under specific stimulation conditions in vivoProceedings of the National Academy of Sciences, 2008
- Toll-like receptor–induced arginase 1 in macrophages thwarts effective immunity against intracellular pathogensNature Immunology, 2008
- Multigenic control of tuberculosis resistance: analysis of a QTL on mouse chromosome 7 and its synergism with sst1Genes & Immunity, 2008
- I/St Mice Hypersusceptible toMycobacterium tuberculosisAre Resistant toM. aviumInfection and Immunity, 2007
- Regulation of granuloma fibrosis by nitric oxide during Mycobacterium avium experimental infectionInternational Journal of Experimental Pathology, 2006
- Genetic architecture of tuberculosis resistance in a mouse model of infectionGenes & Immunity, 2006
- Susceptibility to Buruli ulcer is associated with the SLC11A1 (NRAMP1) D543N polymorphismGenes & Immunity, 2006
- Ipr1 gene mediates innate immunity to tuberculosisNature, 2005